Status:
UNKNOWN
Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA
Lead Sponsor:
Nagoya University
Conditions:
Acquired Aplastic Anemia.
Eligibility:
All Genders
Up to 69 years
Phase:
PHASE3
Brief Summary
The objective of this study is to evaluate the feasibility and effectiveness of immunosuppressive therapy (IST) using rabbit anti-thymocyte globulin (ATG) (Thymoglobuline, Genzyme) for patients with v...
Eligibility Criteria
Inclusion
- Acquired aplastic anemia
- Age: younger than 70 years old
- Severity: SAA, VSAA.
- Interval between diagnosis and registration \<6 months.
- Written informed consent from the caretakers and/or whenever possible consent from the patient.
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT01844635
Start Date
May 1 2012
Last Update
April 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, Nagoya University Graduate School of Medicine
Nagoya, Aichi-ken, Japan, 466-8550